TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33091681

Group type: EXPERIMENTAL
Intervention: Imagery-based mentation for neutral stimuli
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Verbal-linguistic mentation for worrisome stimuli
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Initial period of suppression for neutral stimuli
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Suppression of worrisome stimuli
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Imagery-based mentation for worrisome stimuli
Number of subjects: 62
Study: 34915738

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase before thrombectomy (combination treatment)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Thrombectomy alone (control)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Internal carotid artery occlusions (subgroup)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: M1 occlusions (subgroup)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: M2 occlusions (subgroup)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Bridging therapy (combination treatment)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: M2 occlusion (subgroup)
Number of subjects: 640
Study: 32109133

Group type: EXPERIMENTAL
Intervention: Hab-o Shefa (n = 41)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 81
Study: 35897371

Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shockwave therapy (f‐ESWT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Radial extracorporeal shockwave therapy (r‐ESWT)
Number of subjects: 42
Study: 33482927

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - one weekly session over 16 weeks and three monthly booster sessions
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Psychodynamic Psychotherapy (PDT) - one weekly session over 28 weeks
Number of subjects: 100
Study: 32806727

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (ES)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Passive-recovery control condition (PR)
Number of subjects: 26
Study: 35406079

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 33604696

Group type: EXPERIMENTAL
Intervention: Cycling exercise at 35% of heart rate reserve for 10 minutes after acute mental stress
Number of subjects: 13

Group type: COMPARATOR
Intervention: Seated rest for 10 minutes after acute mental stress
Number of subjects: 13
Study: 32315448

Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 12-hour intervals
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 24-hour intervals
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 48-hour intervals
Number of subjects: 42
Study: 35715934

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32826171

Group type: EXPERIMENTAL
Intervention: SBRT (Stereotactic Body Radiotherapy)
Number of subjects: 15

Group type: COMPARATOR
Intervention: HDR-BRT (High-Dose-Rate Brachytherapy)
Number of subjects: 15
Study: 34369262

Group type: EXPERIMENTAL
Intervention: motion-based beamformer adaptation
Number of subjects: 22

Group type: COMPARATOR
Intervention: conventional beamformer adaptation
Number of subjects: 22
Study: 33383348

Group type: EXPERIMENTAL
Intervention: Oxaliplatin added to preoperative chemoradiotherapy and postoperative chemotherapy, N = 613
Number of subjects: 1236

Group type: COMPARATOR
Intervention: Preoperative chemoradiotherapy followed by total mesorectal excision and postoperative chemotherapy (standard arm), N = 623
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Patients experiencing neurotoxic side-effects (grade 1-4)
Number of subjects: 1236
Study: 35883921

Group type: EXPERIMENTAL
Intervention: Proactive recruitment strategies (community events, school events, recreational centers)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Reactive recruitment strategies (social media advertisements, word of mouth, academic research hub)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Proactive and reactive recruitment methods
Number of subjects: 362
Study: 34154588

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: CDS
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: CDS + SDMT
Number of subjects: 749
Study: 35136160

Group type: EXPERIMENTAL
Intervention: Baseline global quality of life (gQoL)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Emotional functioning, cognitive functioning, depression, insomnia, body image, future perspective
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Social functioning, depression, and fatigue at baseline
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Emotional functioning and fatigue at month 12
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Graphical LASSO network analysis
Number of subjects: 487
Study: 33853802

Group type: EXPERIMENTAL
Intervention: Weekly menu box delivery service including all ingredients and recipes for morning snack, lunch, and afternoon snack, developed by dietitians and meeting menu planning guidelines.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Access to online menu planning training and a menu assessment tool for cooks.
Number of subjects: 8
Study: 35944771

Group type: EXPERIMENTAL
Intervention: Sutureless bioprosthesis (Perceval)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Conventional stented bioprosthesis
Number of subjects: 819
Study: 33342003

Group type: EXPERIMENTAL
Intervention: Combination treatment with testosterone replacement therapy plus alternate-day tadalafil (10 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Testosterone replacement therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Combination treatment
Number of subjects: 29
Study: 35190177

Group type: EXPERIMENTAL
Intervention: Nivolumab (N; 3 mg/kg intravenously on days 1, 15, and 29; n=23)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nivolumab with Ipilimumab (NI; 1 mg/kg intravenously on day 1; n=21)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (chemotherapy or previously untreated patients)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall surgical outcomes after neoadjuvant N or NI
Number of subjects: 44
Study: 34037436

Group type: EXPERIMENTAL
Intervention: Short-term Integrated Amrita Meditation (ST-IAM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Long-term Integrated Amrita Meditation (LT-IAM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Short-term control (ST-control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Long-term control (LT-control)
Number of subjects: 30
Study: 34250977

Group type: EXPERIMENTAL
Intervention: Concomitant administration of CYD-TDV and quadrivalent HPV vaccine
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Sequential administration of CYD-TDV and quadrivalent HPV vaccine
Number of subjects: 528
Study: 36002981

Group type: EXPERIMENTAL
Intervention: Pilot balloon finger palpation for cuff pressure control
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Intermittent cuff pressure control
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Continuous cuff pressure control
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 168
Study: 33884504

Group type: EXPERIMENTAL
Intervention: PACO/NP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PACO/PAS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PLA/NP
Number of subjects: 40

Group type: COMPARATOR
Intervention: PLA/PAS
Number of subjects: 40
Study: 36102519

Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy
Number of subjects: 43
Study: 616739365

Group type: EXPERIMENTAL
Intervention: Sonidegib 200 mg daily
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Sonidegib 800 mg daily
Number of subjects: 230
Study: 35313512

Group type: EXPERIMENTAL
Intervention: exercise+nutrition group
Number of subjects: 26

Group type: COMPARATOR
Intervention: exercise group
Number of subjects: 26
Study: 33751845

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced diet
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Fat-reduced diet
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combined sample (both diets)
Number of subjects: 122
Study: 32107364

Group type: EXPERIMENTAL
Intervention: Low-dose EC-MPS plus low-dose MZR
Number of subjects: 115

Group type: COMPARATOR
Intervention: Low-dose EC-MPS
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard-dose MZR
Number of subjects: 115
Study: 35356618

Group type: EXPERIMENTAL
Intervention: Dignity therapy (4 weeks intervention)
Number of subjects: 120
Study: 36321877

Group type: EXPERIMENTAL
Intervention: Lithium-disilicate crowns
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Zirconia crowns
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both materials
Number of subjects: 60

Group type: COMPARATOR
Intervention: Implants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Adjacent teeth
Number of subjects: 60
Study: 32379201

Group type: COMPARATOR
Intervention: Maternal influenza immunization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meningococcal conjugate vaccine
Number of subjects: 0
Study: 34151820

Group type: EXPERIMENTAL
Intervention: Thoracolumbar manipulation and diaphragmatic release techniques
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group (no active treatment)
Number of subjects: 30
Study: 33504190

Group type: EXPERIMENTAL
Intervention: Dabigatran (150/110 mg BID)
Number of subjects: 5388

Group type: COMPARATOR
Intervention: Aspirin (100 mg QD)
Number of subjects: 5388

Group type: EXPERIMENTAL
Intervention: Meta-analysis of anticoagulant therapy
Number of subjects: 5388
Study: 35791845

Group type: EXPERIMENTAL
Intervention: 30% supramolecular salicylic acid combined with ultra‐pulsed CO2 fractional laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ultra‐pulsed CO2 fractional laser
Number of subjects: 20
Study: 33392782

Group type: EXPERIMENTAL
Intervention: 940 nm laser diode irradiation (Epic 10, Biolase, USA) at 100 mW for 5 seconds
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (aiming beam only)
Number of subjects: 30
Study: 32050663

Group type: EXPERIMENTAL
Intervention: Individuals living close to forested areas
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Individuals in areas with high population density (>400 people per km2)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: General population density
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Traditional gold mining activities
Number of subjects: 1200
Study: 32541215

Group type: EXPERIMENTAL
Intervention: Direct oral feeding (DOF)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard of care (nil‐by‐mouth for 5 days postoperative and tube feeding)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (standard of care)
Number of subjects: 196
Study: 32667428

Group type: EXPERIMENTAL
Intervention: Antibullying intervention consisting of two meetings focused on educative aspects of bullying, with 613 (58.7%) adolescents participating.
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Control group consisting of 430 (41.3%) participants who did not receive the intervention.
Number of subjects: 1043
Study: 35405479

Group type: EXPERIMENTAL
Intervention: Gradual cessation strategy (reduce baseline number of cigarettes per day by 25% over a 4 week period)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Abrupt cessation strategy (assigned a quit date the day they were provided their VNP)
Number of subjects: 66
Study: 35007321

Group type: COMPARATOR
Intervention: Hydroxyurea (HU)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Pegylated interferon-α (PEG)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 168
Study: 33711123

Group type: EXPERIMENTAL
Intervention: Heavyweight mesh
Number of subjects: 412

Group type: COMPARATOR
Intervention: Lightweight mesh
Number of subjects: 412
Study: 35355382

Group type: EXPERIMENTAL
Intervention: DEX-implant
Number of subjects: 52

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 52
Study: 34003273

Group type: EXPERIMENTAL
Intervention: Cumulative use duration of more than 90 days
Number of subjects: 1511

Group type: EXPERIMENTAL
Intervention: Mean daily dose higher than 90 MME
Number of subjects: 1511

Group type: EXPERIMENTAL
Intervention: Opioid-related emergency department visits, hospital readmissions, or all-cause death
Number of subjects: 1511
Study: 32380917

Group type: EXPERIMENTAL
Intervention: Combined physical and cognitive training
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cognitive training alone
Number of subjects: 92

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 92
Study: 35334136

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 760

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760
Study: 33850184

Group type: EXPERIMENTAL
Intervention: IFNβ1a (subcutaneous injections of 12,000 IU on days 1, 3, 6)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IFNβ1b (subcutaneous injections of 8,000,000 IU on days 1, 3, 6)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Lopinavir/Ritonavir and Hydroxychloroquine)
Number of subjects: 60
Study: 37487868

Group type: EXPERIMENTAL
Intervention: LNG13.5-IUD
Number of subjects: 106

Group type: COMPARATOR
Intervention: Cu380-IUD
Number of subjects: 106
Study: 34340527

Group type: EXPERIMENTAL
Intervention: THX‐110 (∆9‐THC 10 mg daily and PEA 800 mg daily)
Number of subjects: 16
Study: 33103934

Group type: EXPERIMENTAL
Intervention: Gut microbiota analysis and profiling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Literature review of factors affecting CD onset
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion on disease modification and prevention
Number of subjects: 0
Study: 32320061

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 99

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 99
Study: 32827412

Group type: EXPERIMENTAL
Intervention: NR-INF-02 at 1000 mg for 84 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: NR-INF-02 at 2000 mg for 84 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: NR-INF-02 (both doses)
Number of subjects: 48
Study: 35134185

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine as post-exposure prophylaxis
Number of subjects: 689

Group type: EXPERIMENTAL
Intervention: Exposure to two suspected index cases
Number of subjects: 689

Group type: EXPERIMENTAL
Intervention: Increased contact time for healthcare workers
Number of subjects: 689

Group type: COMPARATOR
Intervention: County-level incidence
Number of subjects: 689
Study: 34015499

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich seaweed extract (2000 mg/d)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32886710

Group type: EXPERIMENTAL
Intervention: Hero program (experimental group)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 909
Study: 36402056

Group type: EXPERIMENTAL
Intervention: Empowerment-based educative psycho-behavioral program (n=86)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Generic health education program (n=85)
Number of subjects: 171
Study: 32266392

Group type: EXPERIMENTAL
Intervention: Intrauterine device (IUD) provided during surgical TOP or 1-4 weeks following medical TOP.
Number of subjects: 748

Group type: COMPARATOR
Intervention: Control group advised to contact primary health care for follow-up and IUD insertion.
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: IUD intervention during years 0-3.
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: IUD intervention during years 4-5.
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: Overall requested TOPs including TOPs and early pregnancy failures in intervention group.
Number of subjects: 748

Group type: COMPARATOR
Intervention: Overall requested TOPs including TOPs and early pregnancy failures in control group.
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: Subsequent TOPs overall in intervention group.
Number of subjects: 748

Group type: COMPARATOR
Intervention: Subsequent TOPs overall in control group.
Number of subjects: 748
Study: 36215000

Group type: EXPERIMENTAL
Intervention: WL+EX
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: WL+SL
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: WL+EX+SL
Number of subjects: 112
Study: 34185574

Group type: EXPERIMENTAL
Intervention: Targeted re-instruction on hearing aid use and care skills
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard HA orientation (Control)
Number of subjects: 26
Study: 32664361

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) during exercise
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (aerobic and strength training without WB-EMS)
Number of subjects: 34
Study: 35363205

Group type: EXPERIMENTAL
Intervention: Online rational emotive behavior therapy (online REBT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 35
Study: 32049065

Group type: EXPERIMENTAL
Intervention: Push notifications and access to app functionalities
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no access to app functionalities)
Number of subjects: 117
Study: 35177279

Group type: EXPERIMENTAL
Intervention: Topical imiquimod (IMQ) therapy for 16 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Large loop excision of the transformation zone (LLETZ)
Number of subjects: 93
Study: 34453917

Group type: EXPERIMENTAL
Intervention: Sustained inflations
Number of subjects: 70

Group type: COMPARATOR
Intervention: IPPV
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 35091786

Group type: EXPERIMENTAL
Intervention: Daily self-monitoring of blood pressure (BP) for 2 months
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Multiple self-monitoring (BP, body fat, sleeping time, daily step count) for 2 months
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (no self-monitoring) for 2 months
Number of subjects: 161
Study: 35173011

Group type: EXPERIMENTAL
Intervention: Open-door policy (ODP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 0
Study: 32421486

Group type: EXPERIMENTAL
Intervention: Natural matrix biopolymer membrane (NMBM)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (conventional treatment)
Number of subjects: 25
Study: 36197415

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) program with a progressive resistive load of 40‐70% of the maximum inspiratory pressure (PImax) for 30 breaths once a day for 12 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group with a similar protocol at a minimum load of 10 cmH2O
Number of subjects: 65
Study: 33792038

Group type: EXPERIMENTAL
Intervention: 3D simulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: VR simulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2D simulation
Number of subjects: 20
Study: 32382078

Group type: EXPERIMENTAL
Intervention: ExoDx Prostate(IntelliScore) (EPI) test
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Control arm (standard of care)
Number of subjects: 1094
Study: 35930874

Group type: EXPERIMENTAL
Intervention: Self-compassion intervention
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Self-esteem intervention
Number of subjects: 605

Group type: COMPARATOR
Intervention: Benign recollection control
Number of subjects: 605
Study: 32028078

Group type: EXPERIMENTAL
Intervention: Modified Gait Efficacy Scale (mGES)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Shortened mGES (removing certain items)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: 3-item version of mGES
Number of subjects: 424
Study: 34297780

Group type: EXPERIMENTAL
Intervention: Moderate to severe depression
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Moderate to severe anxiety
Number of subjects: 1007
Study: 32458096

Group type: EXPERIMENTAL
Intervention: Zoledronic acid treatment
Number of subjects: 155
Study: 34301203

Group type: EXPERIMENTAL
Intervention: P02 hearing aid
Number of subjects: 73

Group type: COMPARATOR
Intervention: Clip‐II™
Number of subjects: 73

Group type: COMPARATOR
Intervention: Concerto Basic®
Number of subjects: 73
Study: 32209082

Group type: EXPERIMENTAL
Intervention: Workshop intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 25
Study: 34469077

Group type: EXPERIMENTAL
Intervention: Processed microvascular tissue (PMVT) allograft
Number of subjects: 100

Group type: COMPARATOR
Intervention: Collagen alginate dressing
Number of subjects: 100
Study: 33100181

Group type: EXPERIMENTAL
Intervention: Nivolumab treatment (low dose regimen, 40 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nivolumab treatment
Number of subjects: 46
Study: 35997638

Group type: EXPERIMENTAL
Intervention: Indira Gandhi Matritva Sahyog Yojana (IGMSY)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (non-treatment districts)
Number of subjects: 52
Study: 32306747

Group type: EXPERIMENTAL
Intervention: Adjunctive interpersonal and social rhythm therapy (IPSRT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Treatment as usual (general practice medical care)
Number of subjects: 88
Study: 35170379

Group type: EXPERIMENTAL
Intervention: Cake and juice consumption 30 minutes before NST
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Cake and juice consumption + motivational video (15-20 minutes) during NST
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 360
Study: 33595176

Group type: EXPERIMENTAL
Intervention: High-risk drinkers (n=275)
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Moderate drinkers (n=1222)
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Former drinkers (n=263)
Number of subjects: 1760

Group type: EXPERIMENTAL
Intervention: High-risk drinkers (n=275) with metabolic syndrome (MS)
Number of subjects: 1760

Group type: EXPERIMENTAL
Intervention: High-risk drinkers (n=275) with high alcohol consumption
Number of subjects: 1760